Search

everythinglearnresearchcommunity

for

Search:↓

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Young women with PCOS without additional risk factors may have normal heart function.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Polycystic ovary syndrome (PCOS) is more common in urban areas, possibly due to lifestyle and diet, and ignoring it can lead to serious health issues.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Women with PCOS often have liver disease, so liver health checks are important for them.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Women with PCOS often have acne because of high androgen levels, and the article reviewed how to treat this type of acne.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.